Thymosin Beta 4 has been investigated for the treatment of STEMI, Dry Eye, Diabetes, Pressure Ulcers, and Dry Eye Syndrome, among others.
Huashan Hospital of Fudan University, Shanghai, Shanghai, China
Sun Yat-sen University, Guangzhou, Guangdong, China
Shanghai Ruijin Hospital, Shanghai, Shanghai, China
Guangzhou First People's Hospital, Guangzhou, Guangdong, China
Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China
Hangzhou First People's Hospital, Hangzhou, Zhejiang, China
Department of SICU, Research Institute of General Surgery Jinling Hospital, Nanjing, Jiangsu, China, Nanjing, Jiangsu, China
Jinling Hospital, Nanjing, Jiangsu, China
Second Division of Nephrology and Dialysis - Padua Hospital, Padua, Italy
Università degli Studi di Napoli - Federico II, Naples, Italy
Istituto Dermopatico dell'Immacolata (IDI), Rome, Italy
Klinika Chirurgii Naczyń i Angiologii, Lublin, Poland
Healthcare Discoveries LLC, San Antonio, Texas, United States
Sun Yat-sen University, Guangzhou, Guangdong, China
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.